12/23
07:30 am
blco
Bausch + Lomb to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Bausch + Lomb to Participate in the 44th Annual J.P. Morgan Healthcare Conference
12/18
04:11 pm
blco
White men urged to file discrimination claims in anti-DEI escalation [USA TODAY]
Low
Report
White men urged to file discrimination claims in anti-DEI escalation [USA TODAY]
12/17
04:45 pm
blco
Fund Exits $6.6 Million Bausch + Lomb Stake as Shares Lag by 9% This Past Year [Yahoo! Finance]
Low
Report
Fund Exits $6.6 Million Bausch + Lomb Stake as Shares Lag by 9% This Past Year [Yahoo! Finance]
12/17
04:30 pm
blco
Bausch + Lomb Announces Two Board of Directors Appointments
Low
Report
Bausch + Lomb Announces Two Board of Directors Appointments
12/15
03:39 pm
blco
Bausch + Lomb: I Need To See Stability Before Upgrading This Name [Seeking Alpha]
Low
Report
Bausch + Lomb: I Need To See Stability Before Upgrading This Name [Seeking Alpha]
12/14
08:35 am
blco
How Bausch + Lomb's $2.8 Billion Refi and Eye-Care Pipeline Momentum Will Impact Bausch + Lomb (BLCO) Investors [Yahoo! Finance]
Low
Report
How Bausch + Lomb's $2.8 Billion Refi and Eye-Care Pipeline Momentum Will Impact Bausch + Lomb (BLCO) Investors [Yahoo! Finance]
12/12
05:11 pm
blco
Bausch + Lomb Announces Refinancing of Outstanding Term B Loans [Yahoo! Finance]
Low
Report
Bausch + Lomb Announces Refinancing of Outstanding Term B Loans [Yahoo! Finance]
12/12
04:48 pm
blco
Bausch + Lomb Announces Refinancing of Outstanding Term B Loans
Low
Report
Bausch + Lomb Announces Refinancing of Outstanding Term B Loans
12/11
12:32 pm
blco
Why Bausch + Lomb (BLCO) Stock Is Trading Up Today [Yahoo! Finance]
Low
Report
Why Bausch + Lomb (BLCO) Stock Is Trading Up Today [Yahoo! Finance]
12/11
07:20 am
blco
Bausch + Lomb (NYSE:BLCO) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.
Low
Report
Bausch + Lomb (NYSE:BLCO) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.
12/2
12:46 pm
blco
Bausch Health Companies Inc. (BHC) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]
Low
Report
Bausch Health Companies Inc. (BHC) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]
12/2
12:14 pm
blco
Why Bausch + Lomb (BLCO) Stock Is Up Today [Yahoo! Finance]
Low
Report
Why Bausch + Lomb (BLCO) Stock Is Up Today [Yahoo! Finance]
12/1
09:41 am
blco
Bausch + Lomb (BLCO): Is the Current Valuation Overlooked After Recent Share Recovery? [Yahoo! Finance]
Low
Report
Bausch + Lomb (BLCO): Is the Current Valuation Overlooked After Recent Share Recovery? [Yahoo! Finance]
11/18
04:50 pm
blco
Bausch + Lomb to Participate in Citi Global Healthcare Conference [Yahoo! Finance]
Low
Report
Bausch + Lomb to Participate in Citi Global Healthcare Conference [Yahoo! Finance]
11/18
04:30 pm
blco
Bausch + Lomb to Participate in Citi Global Healthcare Conference
Low
Report
Bausch + Lomb to Participate in Citi Global Healthcare Conference
11/18
02:25 am
blco
Bausch + Lomb Corporation (BLCO) Bausch + Lomb Corporation - Analyst/Investor Day Transcript [Seeking Alpha]
Low
Report
Bausch + Lomb Corporation (BLCO) Bausch + Lomb Corporation - Analyst/Investor Day Transcript [Seeking Alpha]
11/16
04:36 am
blco
Is Bausch + Lomb (NYSE:BLCO) Undervalued? A Fresh Look at Its Current Valuation [Yahoo! Finance]
Medium
Report
Is Bausch + Lomb (NYSE:BLCO) Undervalued? A Fresh Look at Its Current Valuation [Yahoo! Finance]
11/14
10:56 am
blco
Bausch + Lomb (NYSE:BLCO) had its price target raised by analysts at Royal Bank Of Canada from $17.00 to $19.00. They now have an "outperform" rating on the stock.
Low
Report
Bausch + Lomb (NYSE:BLCO) had its price target raised by analysts at Royal Bank Of Canada from $17.00 to $19.00. They now have an "outperform" rating on the stock.
11/14
10:32 am
blco
Bausch + Lomb (NYSE:BLCO) had its price target raised by analysts at Wells Fargo & Company from $16.00 to $17.00. They now have an "equal weight" rating on the stock.
Low
Report
Bausch + Lomb (NYSE:BLCO) had its price target raised by analysts at Wells Fargo & Company from $16.00 to $17.00. They now have an "equal weight" rating on the stock.
11/13
08:06 am
blco
Bausch + Lomb CEO Brent Saunders on growth outlook: Biggest contributor will be in surgical [CNBC]
Medium
Report
Bausch + Lomb CEO Brent Saunders on growth outlook: Biggest contributor will be in surgical [CNBC]
11/13
07:28 am
blco
Bausch + Lomb to Highlight Company Transformation and Growth Strategy at Investor Day [Yahoo! Finance]
Medium
Report
Bausch + Lomb to Highlight Company Transformation and Growth Strategy at Investor Day [Yahoo! Finance]
11/13
07:00 am
blco
Bausch + Lomb to Highlight Company Transformation and Growth Strategy at Investor Day
Medium
Report
Bausch + Lomb to Highlight Company Transformation and Growth Strategy at Investor Day
11/10
07:10 am
blco
Bausch + Lomb Reports More Than 690,000 Pounds of Contacts Lens, Lens Care and Eye Care Materials Collected Through ONE By ONE Recycling Program [Yahoo! Finance]
Low
Report
Bausch + Lomb Reports More Than 690,000 Pounds of Contacts Lens, Lens Care and Eye Care Materials Collected Through ONE By ONE Recycling Program [Yahoo! Finance]
11/10
06:59 am
blco
Bausch + Lomb Reports More Than 690,000 Pounds of Contacts Lens, Lens Care and Eye Care Materials Collected Through ONE By ONE Recycling Program
Low
Report
Bausch + Lomb Reports More Than 690,000 Pounds of Contacts Lens, Lens Care and Eye Care Materials Collected Through ONE By ONE Recycling Program
11/3
04:30 pm
blco
Bausch + Lomb to Hold Investor Day on Nov. 13
Low
Report
Bausch + Lomb to Hold Investor Day on Nov. 13